Skip to main content

Advertisement

Log in

Usefulness of Hemodynamic Device-Based Optimization in Heterogeneous Patients Implanted with Cardiac Resynchronization Therapy Defibrillator

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Optimization of the atrioventricular (AV) and interventricular (VV) timings of the CRT is the most supposed correctable variable to improve the rate of CRT responder. The aim of the present study has been to evaluate if there is a specific subgroup of patients who can actually benefit the most from a hemodynamic optimization of AV. This is a prospective, observational single-center study that enrolled consecutive patients with clinical indication for CRT; all patients were implanted with CRT-D devices with SonR technology, able to automatically adjust AV and VV delay on a weekly basis. Among 57 patients, 39 (69%) showed a LVESV reduction > 15%. The SonR was able to modify the pacing parameters, but an increase of left atrial diameter was associated to a reduced AV variability, suggesting that an impaired left atrial function could potentially reduce the ability of the SonR algorithm to adjust the correct timing of pacing.

Patients with respectively a high (A) and low (B) AV timing variability, among several parameters that could potentially influence the AV timing, only left atrial dimensions demonstrated a significant impact. In fact an increase of left atrial diameter was associated to a reduced AV variability, suggesting that an impaired left atrial function could potentially reduce the ability of the SonR algorithm to adjust the correct timing of pacing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Brignole, M., et al. (2013). 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: The task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). European Heart Journal, 34, 2281–2329.

    Article  PubMed  Google Scholar 

  2. Abraham, W. T., et al. (2002). Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine, 346, 1845–1853.

    Article  PubMed  Google Scholar 

  3. Bristow, M. R., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England Journal of Medicine, 350, 2140–2150.

    Article  CAS  PubMed  Google Scholar 

  4. van Bommel, R. J., et al. (2009). Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: A PROSPECT (predictors of response to CRT) sub-analysis. European Heart Journal, 30, 2470–2477.

    Article  PubMed  Google Scholar 

  5. Chung, E. S., et al. (2008). Results of the predictors of response to CRT (PROSPECT) trial. Circulation, 117, 2608–2616.

    Article  PubMed  Google Scholar 

  6. Auricchio, A., & Prinzen, F. W. (2011). Non-responders to cardiac resynchronization therapy: The magnitude of the problem and the issues. Circulation Journal, 75, 521–527.

    Article  PubMed  Google Scholar 

  7. Mullens, W., et al. (2009). Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. Journal of the American College of Cardiology, 53, 765–773.

    Article  PubMed  Google Scholar 

  8. Auricchio, A., et al. (2002). Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. Journal of the American College of Cardiology, 39, 1163–1169.

    Article  PubMed  Google Scholar 

  9. Auricchio, A., et al. (1999). Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation, 99, 2993–3001.

    Article  CAS  PubMed  Google Scholar 

  10. Ellenbogen, K. A., et al. (2010). Primary results from the SmartDelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation, 122, 2660–2668.

    Article  PubMed  Google Scholar 

  11. Martin, D. O., et al. (2012). Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: Results of the adaptive CRT trial. Heart Rhythm, 9, 1807–1814.

    Article  PubMed  Google Scholar 

  12. Abraham, W. T., et al. (2010). Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. American Heart Journal, 159, 944–948.e941.

    Article  PubMed  Google Scholar 

  13. Ritter, P., et al. (2012). A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace, 14, 1324–1333.

    Article  PubMed  Google Scholar 

  14. Rickards, A. F., Bombardini, T., Corbucci, G., & Plicchi, G. (1996). An implantable intracardiac accelerometer for monitoring myocardial contractility. The Multicenter PEA Study Group. Pacing and Clinical Electrophysiology, 19, 2066–2071.

    Article  CAS  PubMed  Google Scholar 

  15. Gorcsan, J., et al. (2008). Echocardiography for cardiac resynchronization therapy: Recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony writing group endorsed by the Heart Rhythm Society. Journal of the American Society of Echocardiography, 21, 191–213.

    Article  PubMed  Google Scholar 

  16. Zhang, Q., et al. (2008). The role of repeating optimization of atrioventricular interval during interim and long-term follow-up after cardiac resynchronization therapy. International Journal of Cardiology, 124, 211–217.

    Article  PubMed  Google Scholar 

  17. Delnoy, P. P., et al. (2013). Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: A post hoc analysis of the clinical evaluation on advanced resynchronization (CLEAR) pilot study. Europace, 15, 1174–1181.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ponikowski, P., et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Kardiologia Polska, 74, 1037–1147.

    Article  PubMed  Google Scholar 

  19. Brugada, J., et al. (2017). Contractility sensor-guided optimization of cardiac resynchronization therapy: Results from the RESPOND-CRT trial. European Heart Journal, 38, 730–738.

    CAS  PubMed  Google Scholar 

  20. Covino, G., et al. (2014). A novel fluoroscopic method of measuring right-to-left interlead distance as a predictor of reverse left ventricular remodeling after cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology, 39, 153–159.

    Article  PubMed  Google Scholar 

  21. D'Onofrio, A., et al. (2014). Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration. Journal of Cardiovascular Electrophysiology, 25, 500–506.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmine Ciardiello.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights

All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation and with the Helsinki declaration of 1975, as revisited in 2000.

Informed Consent

Informed consent was obtained from all patients for being included in the study.

Additional information

Associate Editor Sunil Kapur oversaw the review of this article

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Covino, G., Volpicelli, M., Ciardiello, C. et al. Usefulness of Hemodynamic Device-Based Optimization in Heterogeneous Patients Implanted with Cardiac Resynchronization Therapy Defibrillator. J. of Cardiovasc. Trans. Res. 13, 938–943 (2020). https://doi.org/10.1007/s12265-020-10004-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-020-10004-9

Keywords

Navigation